ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Taiko Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 5.99%
- The company has been able to generate a Return on Equity (avg) of 5.99% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -16.57% and Operating profit at -34.62% over the last 5 years
3
Underperformed the market in the last 1 year
- The stock has generated a return of 3.86% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 36.73%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Taiko Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Taiko Pharmaceutical Co., Ltd.
3.86%
-0.50
47.64%
Japan Nikkei 225
36.73%
1.30
28.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-16.57%
EBIT Growth (5y)
-34.62%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
0.59
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.85%
ROE (avg)
5.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.57
EV to EBIT
20.68
EV to EBITDA
13.34
EV to Capital Employed
1.93
EV to Sales
1.57
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
9.32%
ROE (Latest)
13.05%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
DIVIDEND PAYOUT RATIO(Y)
Highest at 65.28%
DEBT-EQUITY RATIO
(HY)
Lowest at -40.39 %
DIVIDEND PER SHARE(HY)
Highest at JPY 2.62
NET SALES(Q)
Highest at JPY 2,168 MM
-4What is not working for the Company
NET PROFIT(9M)
At JPY 520.28 MM has Grown at -31.27%
RAW MATERIAL COST(Y)
Grown by 7.08% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.62 times
Here's what is working for Taiko Pharmaceutical Co., Ltd.
Net Sales
At JPY 2,168 MM has Grown at 45.94%
over average net sales of the previous four periods of JPY 1,485.5 MMMOJO Watch
Near term sales trend is very positive
Net Sales (JPY MM)
Net Sales
Highest at JPY 2,168 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Debt-Equity Ratio
Lowest at -40.39 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Dividend per share
Highest at JPY 2.62
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (JPY)
Dividend Payout Ratio
Highest at 65.28%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Depreciation
Highest at JPY 72 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Taiko Pharmaceutical Co., Ltd.
Net Profit
At JPY 520.28 MM has Grown at -31.27%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
Debtors Turnover Ratio
Lowest at 2.62 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 7.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
